New CJEU Referral requesting clarification of the term “human embryo” for patent purposes.

Boletín 31 marzo 2023

The patenting of inventions relating to human embryonic stem cells remains a controversial topic in Europe. At the forefront of this debate is the need to balance fundamental human rights with a patent system that encourages scientific research in areas having the potential to revolutionise the treatment of human disease.